Drugs / intrathecal cytarabine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02660762 Background | Jan 2016 → Jan 2019 | acute lymphoblastic leukemia | Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | intrathecal cytarabine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02660762 ↗ |
| Route | Intrathecal | “50 mg intrathecal cytarabine” NCT02660762 ↗ |